Aspirin resistance in patients with ischemic stroke
INTRODUCTION[|]Aspirin is the basic agent of antithrombotic treatment in ischemic cerebrovascular disease (CVD) patients. However several patients don't respond to treatment and therefore aspirin resistance term has been used lately. Recent studies have shown that aspirin resistance incidence i...
Main Authors: | Anıl Bulut, Sultan Çağırıcı, Vildan Yayla, Murat Çabalar, Songül Şenadım |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2019-01-01
|
Series: | Southern Clinics of Istanbul Eurasia |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-40427 |
Similar Items
-
Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
by: Alec A. Schmaier, et al.
Published: (2018-06-01) -
Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic Attack
by: Kailash Krishnan, et al.
Published: (2023-05-01) -
Genetic Association Study and Machine Learning to Investigate Differences in Platelet Reactivity in Patients with Acute Ischemic Stroke Treated with Aspirin
by: Anna Ikonnikova, et al.
Published: (2022-10-01) -
Comparison of Different Laboratory Tests to Identify “Aspirin Resistance” and Risk of Vascular Events among Ischaemic Stroke Patients: A Double-Blind Study
by: Narayanaswamy Venketasubramanian, et al.
Published: (2022-05-01) -
Aspirin‐induced urticaria in a recently diagnosed ischemic stroke patient: A case report and literature review
by: Abhinav Dahal, et al.
Published: (2023-08-01)